BackHarpoon Therapeutics Overview
Harpoon Therapeutics Inc

Harpoon Therapeutics Discounted Cash Flow

DCF Analysis for HARP.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$24.80

Current Fair Value

$24.80
7.8% Upside

Undervalued by 7.8% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading